Kapil Sikka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kapil Sikka has a total of 278 co-authors. Here are the top co-authors by number of shared publications:
- Alok Thakar
Department of Otorhinolaryngology, All India Institute of Medical Sciences, New Delhi, India
34 shared publications - Hitesh Verma
Department of Otorhinolaryngology and Head-Neck Surgery, All India Institute of Medical Sciences, New Delhi, India
24 shared publications - Chirom Amit Singh
Department of Otorhinolaryngology, All India Institute of Medical Sciences, New Delhi, India
15 shared publications Alok Thakar
All India Institute of Medical Sciences
14 shared publications- Smriti Panda
Department of Otorhinolaryngology and Head and Neck Surgery All India Institute of Medical Sciences New Delhi India
12 shared publications - Rajeev Kumar
Department of Otorhinolaryngology and Head – Neck Surgery, All India Institute of Medical Sciences, New Delhi, India
10 shared publications
Latest Publications
- 28 August 2026
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 78 (10) , 5112-5116
Altered Metal Ion Homeostasis in Fungal Rhinosinusitis: A Serum Analysis
- 28 August 2026
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 78 (10) , 5112-5116
Altered Metal Ion Homeostasis in Fungal Rhinosinusitis: A Serum Analysis
- 20 August 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (11) , 7421-7430
Frequency, predictors, and prognostic impact of intraparotid lymph node recurrence in oral cavity squamous cell carcinoma: a retrospective case-control study
Background Intraparotid lymph node (PLN) recurrence from oral cavity squamous cell carcinoma (OCSCC) is uncommon and inadequately characterised, with limited literature regarding its frequency, predictors, and prognostic implications. Methods A retrospective analysis was conducted on consecutive patients with OCSCC who underwent upfront surgery at a tertiary care centre from 2022 to 2024. Patients with clinical or radiological evidence of PLN recurrence were identified. A site-matched cohort of 100 consecutive patients with OCSCC treated surgically during the same time frame, and patients with non-PLN recurrences served as controls. Results Among 939 surgically treated OCSCC patients, 22 (2.34%) developed PLN recurrence. Parotid recurrences occurred early, with a median time to detection of 3 months (range, 2–13 months). Presence of greater than 4 metastatic lymph nodes was the only independent predictor of PLN recurrence (OR 5.78, 95% CI 1.43–23.28; p = 0.0136). Patients with PLN recurrences demonstrated significantly inferior survival outcomes. Compared with patients with recurrence outside PLN, patients with PLN recurrences had a higher incidence of tumour location in the gingivobuccal complex, skin involvement, lymphovascular invasion, close margins and belonging to stage IVb. Recurrence in the PLN portends poor OS compared to recurrence outside PLN (HR: 1.98, 95% CI:0.99 to 3.94), with successful salvage possible in only 1 out of 22 patients in the former compared to 9 out of 46 in the latter. Conclusion Greater than 4 metastatic cervical lymph nodes, location in the gingivobuccal complex, skin involvement, stage IVb, lymphovascular invasion, and margins less than 5 mm are predictors of failure in the PLN.
- 20 August 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (11) , 7421-7430
Frequency, predictors, and prognostic impact of intraparotid lymph node recurrence in oral cavity squamous cell carcinoma: a retrospective case-control study
Background Intraparotid lymph node (PLN) recurrence from oral cavity squamous cell carcinoma (OCSCC) is uncommon and inadequately characterised, with limited literature regarding its frequency, predictors, and prognostic implications. Methods A retrospective analysis was conducted on consecutive patients with OCSCC who underwent upfront surgery at a tertiary care centre from 2022 to 2024. Patients with clinical or radiological evidence of PLN recurrence were identified. A site-matched cohort of 100 consecutive patients with OCSCC treated surgically during the same time frame, and patients with non-PLN recurrences served as controls. Results Among 939 surgically treated OCSCC patients, 22 (2.34%) developed PLN recurrence. Parotid recurrences occurred early, with a median time to detection of 3 months (range, 2–13 months). Presence of greater than 4 metastatic lymph nodes was the only independent predictor of PLN recurrence (OR 5.78, 95% CI 1.43–23.28; p = 0.0136). Patients with PLN recurrences demonstrated significantly inferior survival outcomes. Compared with patients with recurrence outside PLN, patients with PLN recurrences had a higher incidence of tumour location in the gingivobuccal complex, skin involvement, lymphovascular invasion, close margins and belonging to stage IVb. Recurrence in the PLN portends poor OS compared to recurrence outside PLN (HR: 1.98, 95% CI:0.99 to 3.94), with successful salvage possible in only 1 out of 22 patients in the former compared to 9 out of 46 in the latter. Conclusion Greater than 4 metastatic cervical lymph nodes, location in the gingivobuccal complex, skin involvement, stage IVb, lymphovascular invasion, and margins less than 5 mm are predictors of failure in the PLN.
- 16 February 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (5) , 3297-3304
Factors associated with occult ipsilateral and contralateral nodal metastasis in resectable lateralized laryngeal and hypopharyngeal malignancies
- 16 February 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (5) , 3297-3304
Factors associated with occult ipsilateral and contralateral nodal metastasis in resectable lateralized laryngeal and hypopharyngeal malignancies
- 19 August 2025
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 139 (12) , 1202-1207
Impact of residual hearing on outcomes of cochlear implantation in paediatric population: An Ambispective Cohort study
Objective: Cochlear implantation has transformed management of children with severe to profound hearing loss but the influence of residual hearing on outcomes remains debatable. Methods: This ambispective study analysed 48 prelingually deaf children aged 3–8 years to evaluate auditory, speech and language outcomes following unilateral cochlear implantation. Participants were grouped based on presence of residual hearing and tracked up to 3 years post implantation. Results: Early improvements in auditory and speech perception were significantly higher in candidates with residual hearing but equalised by 12 months. Language outcomes initially favoured RH group with no significant difference beyond 18 months. Owing to gradual development of language, it remained below age-appropriate levels. Parental satisfaction scores were consistently better in RH group, driven by early post-implantation gains. Conclusion: Residual hearing positively impacts early outcomes in cochlear implant recipients but influence diminishes over time.
- 19 August 2025
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 139 (12) , 1202-1207
Impact of residual hearing on outcomes of cochlear implantation in paediatric population: An Ambispective Cohort study
Objective: Cochlear implantation has transformed management of children with severe to profound hearing loss but the influence of residual hearing on outcomes remains debatable. Methods: This ambispective study analysed 48 prelingually deaf children aged 3–8 years to evaluate auditory, speech and language outcomes following unilateral cochlear implantation. Participants were grouped based on presence of residual hearing and tracked up to 3 years post implantation. Results: Early improvements in auditory and speech perception were significantly higher in candidates with residual hearing but equalised by 12 months. Language outcomes initially favoured RH group with no significant difference beyond 18 months. Owing to gradual development of language, it remained below age-appropriate levels. Parental satisfaction scores were consistently better in RH group, driven by early post-implantation gains. Conclusion: Residual hearing positively impacts early outcomes in cochlear implant recipients but influence diminishes over time.
- 23 June 2025
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 77 (9) , 3625-3631
Predictive Value of ACE 27 Tool for Surgical Outcomes in Geriatric Head and Neck Cancer in the Indian Subcontinent
- 23 June 2025
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 77 (9) , 3625-3631
Predictive Value of ACE 27 Tool for Surgical Outcomes in Geriatric Head and Neck Cancer in the Indian Subcontinent
- Open Access
- 1 April 2025
- Published by Korean Sleep Society in Journal of Sleep Medicine
- Vol. 22 (1) , 17-25
Evaluation of Eustachian Tube Function and Acid Reflux With Site of Obstruction in Obstructive Sleep Apnea
Objectives: Obstructive sleep apnea (OSA) is a multi-level airway disease, and the specific site of obstruction may influence associated conditions such as eustachian tube dysfunction (ETD) and gastroesophageal reflux disease (GERD). This study aimed to explore the relationship between OSA, ETD, acid reflux, and the anatomical site of obstruction. Methods: Participants were assessed using validated questionnaires for OSA, ETD, and reflux symptoms. The site of upper airway collapse was determined objectively using apneagraphy or sleep MRI. Acid reflux symptoms were evaluated using a standardized reflux symptom questionnaire, and 24-hour pH monitoring was done when indicated. ETD was assessed both subjectively and objectively through the Toynbee maneuver. Results: Sixty-three individuals completed the evaluation. The mean age was 40.4 years, and the mean BMI was 28.1 kg/m2. Retroglossal obstruction was observed in 76.1% (48/63), while 23.9% (15/63) had retropalatal obstruction. ETD was diagnosed in 53% of participants, and GERD in 38% by objective testing. A statistically significant association was found between retroglossal collapse and complete ETD (p=0.02). However, no significant link was noted between the obstruction site and laryngopharyngeal reflux or partial ETD. Additionally, salivary pepsin levels showed no correlation with reflux (p=0.412). Conclusions: OSA is frequently accompanied by ETD and GERD. Notably, retroglossal obstruction appears to be significantly associated with complete ETD, suggesting a potential site-specific impact. These findings underscore the importance of anatomical localization in understanding OSA-related comorbidities and warrant further investigation in larger multicenter studies.
- 1 April 2025
- Published by Korean Sleep Society in Journal of Sleep Medicine
- Vol. 22 (1) , 17-25
Open AccessEvaluation of Eustachian Tube Function and Acid Reflux With Site of Obstruction in Obstructive Sleep Apnea
Objectives: Obstructive sleep apnea (OSA) is a multi-level airway disease, and the specific site of obstruction may influence associated conditions such as eustachian tube dysfunction (ETD) and gastroesophageal reflux disease (GERD). This study aimed to explore the relationship between OSA, ETD, acid reflux, and the anatomical site of obstruction. Methods: Participants were assessed using validated questionnaires for OSA, ETD, and reflux symptoms. The site of upper airway collapse was determined objectively using apneagraphy or sleep MRI. Acid reflux symptoms were evaluated using a standardized reflux symptom questionnaire, and 24-hour pH monitoring was done when indicated. ETD was assessed both subjectively and objectively through the Toynbee maneuver. Results: Sixty-three individuals completed the evaluation. The mean age was 40.4 years, and the mean BMI was 28.1 kg/m2. Retroglossal obstruction was observed in 76.1% (48/63), while 23.9% (15/63) had retropalatal obstruction. ETD was diagnosed in 53% of participants, and GERD in 38% by objective testing. A statistically significant association was found between retroglossal collapse and complete ETD (p=0.02). However, no significant link was noted between the obstruction site and laryngopharyngeal reflux or partial ETD. Additionally, salivary pepsin levels showed no correlation with reflux (p=0.412). Conclusions: OSA is frequently accompanied by ETD and GERD. Notably, retroglossal obstruction appears to be significantly associated with complete ETD, suggesting a potential site-specific impact. These findings underscore the importance of anatomical localization in understanding OSA-related comorbidities and warrant further investigation in larger multicenter studies.
- 25 December 2024
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 53, 100784
Audit for antifungal treatment usage in adults with invasive fungal infection: A prospective observational study
- 25 December 2024
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 53, 100784
Audit for antifungal treatment usage in adults with invasive fungal infection: A prospective observational study
- 12 December 2024
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 282 (4) , 2095-2103
Office-based flexible endoscopic guided biopsy: single-center feasibility analysis
Background Direct laryngoscopy and biopsy have been the standard of care for biopsy of lesions arising from the upper aerodigestive tract (UADT). The requirement of general anesthesia is often a prerequisite. Procedures performed under the laryngeal block and local anesthesia are not viewed as appropriate from the point of view of patient comfort. Office-based flexible guided biopsy offers a less invasive alternative for obtaining biopsies from UADT. Objective To evaluate the yield, accuracy, feasibility, and safety of office-based flexible fiber-optic endoscope-directed biopsy (FEB) for laryngeal & pharyngeal lesions. Methods Setting- Tertiary care referral center.Retrospective cohort of FEB procedures undertaken in the period from June-December 2022. Results The study sample included 181 consecutive patients (median age 59 years) with lesions in supraglottis-25.4%, glottis-20.4%, nasopharynx-6%, oropharynx (base tongue/vallecula)-24.8%, and hypopharynx(pyriform fossa)-23.2%. The median time from outpatient visit to FEB was 1.9 days (1–4 days). Malignancy was confirmed in 166/181 patients, with 8 pre-malignant and 7 benign lesions. FEB confirmed the appropriate diagnosis in 159/181 (88.1%), and a repeat FEB in the 22 non-diagnostic situations yielded a diagnosis in another 8 (92.8% overall). The remaining 14 patients were appropriately diagnosed by a subsequent operating room endoscopy. The rate of conversion to direct laryngoscopy biopsy was approximately 7.73%. FEB demonstrated sensitivity (86.8%), specificity (100%), Positive Predictive Value (100%), Negative Predictive Value (23.3%), and overall Accuracy (87.29%). Univariate analysis indicated poor diagnostic yield for nasopharynx subsite (OR – 0.15; p = 0.003) and post-radiation/chemoradiation cases(OR – 7.04; p = 0.05). Multivariate analysis of the impact of patient characteristics, lesion subsite/morphology, and prior tracheostomy did not reveal a statistically significant association with histological yield. Mean biopsy time was 8 min with minor complications (pain/ minor bleeding) in 29/203 FEB procedures (14.28%), and major complications in 12(5.9%) (significant bleeding-2, airway compromise-9; death-1). Conclusion Office-based FFB is a viable alternative to direct laryngoscopic guided biopsy with acceptable sensitivity and specificity. Appropriate utilization of FFB will reduce the need for direct laryngoscopy.
- 12 December 2024
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 282 (4) , 2095-2103
Office-based flexible endoscopic guided biopsy: single-center feasibility analysis
Background Direct laryngoscopy and biopsy have been the standard of care for biopsy of lesions arising from the upper aerodigestive tract (UADT). The requirement of general anesthesia is often a prerequisite. Procedures performed under the laryngeal block and local anesthesia are not viewed as appropriate from the point of view of patient comfort. Office-based flexible guided biopsy offers a less invasive alternative for obtaining biopsies from UADT. Objective To evaluate the yield, accuracy, feasibility, and safety of office-based flexible fiber-optic endoscope-directed biopsy (FEB) for laryngeal & pharyngeal lesions. Methods Setting- Tertiary care referral center.Retrospective cohort of FEB procedures undertaken in the period from June-December 2022. Results The study sample included 181 consecutive patients (median age 59 years) with lesions in supraglottis-25.4%, glottis-20.4%, nasopharynx-6%, oropharynx (base tongue/vallecula)-24.8%, and hypopharynx(pyriform fossa)-23.2%. The median time from outpatient visit to FEB was 1.9 days (1–4 days). Malignancy was confirmed in 166/181 patients, with 8 pre-malignant and 7 benign lesions. FEB confirmed the appropriate diagnosis in 159/181 (88.1%), and a repeat FEB in the 22 non-diagnostic situations yielded a diagnosis in another 8 (92.8% overall). The remaining 14 patients were appropriately diagnosed by a subsequent operating room endoscopy. The rate of conversion to direct laryngoscopy biopsy was approximately 7.73%. FEB demonstrated sensitivity (86.8%), specificity (100%), Positive Predictive Value (100%), Negative Predictive Value (23.3%), and overall Accuracy (87.29%). Univariate analysis indicated poor diagnostic yield for nasopharynx subsite (OR – 0.15; p = 0.003) and post-radiation/chemoradiation cases(OR – 7.04; p = 0.05). Multivariate analysis of the impact of patient characteristics, lesion subsite/morphology, and prior tracheostomy did not reveal a statistically significant association with histological yield. Mean biopsy time was 8 min with minor complications (pain/ minor bleeding) in 29/203 FEB procedures (14.28%), and major complications in 12(5.9%) (significant bleeding-2, airway compromise-9; death-1). Conclusion Office-based FFB is a viable alternative to direct laryngoscopic guided biopsy with acceptable sensitivity and specificity. Appropriate utilization of FFB will reduce the need for direct laryngoscopy.
- 31 October 2024
- Published by Springer Nature in Endocrine Pathology
- Vol. 35 (4) , 419-431
Unravelling the Reasons Behind Limited Response to Anti-PD Therapy in ATC: A Comprehensive Evaluation of Tumor-Infiltrating Immune Cells and Checkpoints
Inhibiting the immune checkpoint (ICP) PD-1 based on PD-L1 expression status has revolutionized the treatment of various cancers, yet its efficacy in anaplastic thyroid carcinoma (ATC) remains limited. The therapeutic response depends upon multiple factors, particularly the conduciveness of the tumor’s immune milieu. This study comprehensively evaluated and classified ATC’s immune microenvironment (IME) to elucidate the factors behind suboptimal response to anti-PD therapy. Utilizing multiplex-immunofluorescence and immunohistochemistry, we retrospectively analyzed 26 cases of ATC for expression of ICPs PD-L1, PD-1, CTLA4, TIM3, and Galectin-9 and tumor-infiltrating cytotoxic T lymphocytes (CTL)—the effector cells, the anti-tumor NK cells, the immune-inhibitory myeloid-derived suppressor (MDSC) and regulatory T (Treg) cells, and B lymphocytes. Most ATCs (65%) exhibited PD-L1 positivity, but only 31%, in addition, had abundant CTL (type I IME), a combination associated with a better response to ICP inhibition. Additionally, PD-1 expression levels on CTL were low/absent in most cases—a “target-missing” situation—unfavorable for an adequate therapeutic response. All but one ATC showed nuclear Galectin-9 expression. The documentation of nuclear expression of Galectin-9 akin to benign thyroid is a first, and its role in ATC pathobiology needs further elucidation. In addition to less abundant PD-1 expression on CTL, the presence of MDSC, Treg, and exhausted cytotoxic T lymphocytes in the immune milieu of ATC can contribute to anti-PD resistance. TIM3, the most frequently expressed ICP on CTL, followed by CTLA4, provides alternate therapeutic targets in ATC. The co-expression of multiple immune checkpoints is of great interest for ATC since these data also open the avenue for combination therapies.
- 31 October 2024
- Published by Springer Nature in Endocrine Pathology
- Vol. 35 (4) , 419-431
Unravelling the Reasons Behind Limited Response to Anti-PD Therapy in ATC: A Comprehensive Evaluation of Tumor-Infiltrating Immune Cells and Checkpoints
Inhibiting the immune checkpoint (ICP) PD-1 based on PD-L1 expression status has revolutionized the treatment of various cancers, yet its efficacy in anaplastic thyroid carcinoma (ATC) remains limited. The therapeutic response depends upon multiple factors, particularly the conduciveness of the tumor’s immune milieu. This study comprehensively evaluated and classified ATC’s immune microenvironment (IME) to elucidate the factors behind suboptimal response to anti-PD therapy. Utilizing multiplex-immunofluorescence and immunohistochemistry, we retrospectively analyzed 26 cases of ATC for expression of ICPs PD-L1, PD-1, CTLA4, TIM3, and Galectin-9 and tumor-infiltrating cytotoxic T lymphocytes (CTL)—the effector cells, the anti-tumor NK cells, the immune-inhibitory myeloid-derived suppressor (MDSC) and regulatory T (Treg) cells, and B lymphocytes. Most ATCs (65%) exhibited PD-L1 positivity, but only 31%, in addition, had abundant CTL (type I IME), a combination associated with a better response to ICP inhibition. Additionally, PD-1 expression levels on CTL were low/absent in most cases—a “target-missing” situation—unfavorable for an adequate therapeutic response. All but one ATC showed nuclear Galectin-9 expression. The documentation of nuclear expression of Galectin-9 akin to benign thyroid is a first, and its role in ATC pathobiology needs further elucidation. In addition to less abundant PD-1 expression on CTL, the presence of MDSC, Treg, and exhausted cytotoxic T lymphocytes in the immune milieu of ATC can contribute to anti-PD resistance. TIM3, the most frequently expressed ICP on CTL, followed by CTLA4, provides alternate therapeutic targets in ATC. The co-expression of multiple immune checkpoints is of great interest for ATC since these data also open the avenue for combination therapies.